See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.56▲ 1.10%
← EMFD page
XStocksXray
Market X-Ray report · 22 October 2026

Emaar Misr for Development (EMFD)

Egyptian Exchange · Egypt · prices in EGP · close of 22 Oct 2026

Key indicators

Last closeEGP 11.51
52-week range8.20 – 15.30
Return, 1 month / 3 months−14.6% / −2.0%
Return, 1 year / 3 years+27.7% / +258.6%
TrendAbove 200-day, below 50-day
RSI (14)35
Volatility (1 year)35.3%
Worst drawdown (1 year)-22.8%
Average daily value traded100.61M EGP
Dividend yield–

Market X-Ray price-based

69/ 100 · High confidence · ahead of 88% of stocks on this exchange
Trend61
Momentum60
Stability (higher is calmer)77
Liquidity88
Income–

Five-year price chart navy: price · brown: 200-day average

1.495.038.5812.1215.662021-102023-012024-042025-072026-10

About the company

Emaar Misr for Development is an Egyptian property developer based in Cairo and part of the Emaar group. It builds and sells homes in planned residential communities, including apartments, villas and townhouses, along with retail, hospitality and leisure space within its developments. Its projects serve homebuyers and investors in the Cairo area and on the Mediterranean coast, and it also runs hotels and commercial facilities attached to its communities.

On this site Emaar Misr for Development appears as a stock on the Egyptian Exchange (Egypt), code EMFD, with prices in Egyptian pounds (EGP). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Emaar Misr for Development (EMFD) trades on the Egyptian Exchange in Egypt. It last closed at EGP 11.51 on 22 October 2026.

Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 35 of 276 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 27.7% and over the last three months it fell 2.0%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Emaar Misr for Development (EMFD)

The five lenses in numbers each metric is ranked against the other stocks on Egyptian Exchange

Lens and metricValueScoreReading
Trend61 · FairMixed trend against its averages.
Above 200-day average4.9%
From 52-week high-22.8%
Momentum60 · FairTypical recent returns for this exchange.
3-month return-2.0%
6-month return16.3%
12-month return, skipping the last month49.6%
Stability (higher is calmer)77 · StrongCalmer than most: low volatility and shallow drawdowns.
Volatility, 1 year (lower is calmer)35.3%
Worst drawdown, 1 year (smaller is calmer)-22.8%
Liquidity88 · StrongTrades actively.
Average daily value traded100.61M EGP
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
  • Liquidity: Trades actively.

Weak spots

No lens is weak against its exchange.

Returns

1 week−4.8%
1 month−14.6%
3 months−2.0%
6 months+16.3%
1 year+27.7%
3 years+258.6%
5 years+391.9%

Signals

50-day / 200-day average12.92 / 10.98
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.58

Technical summary

DailyBearish5 bullish · 1 neutral · 10 bearish
WeeklyBullish7 bullish · 1 neutral · 4 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Egyptian Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026